Letter: hepatitis B virus infection and risk of multiple myeloma—a meta‐analysis of cohort studies

Abstract

LINKED CONTENTThis article is linked to Su et al paper. To view this article, visit https://doi.org/10.1111/apt.15132 and https://doi.org/10.1111/apt.15607.

Letter: hepatitis B virus infection and risk of multiple myeloma—a meta‐analysis of cohort studies. Authors' reply

“…

criteria. 1,[5][6][7][8][9] The pooled OR from these six cohort studies was 1.23 (95% CI 0.89-1.69; P = 0.202; I 2 = 22.8%; P herterogeneity = 0.262) with no statistical significance ( Figure 1). In conclusion, our meta-analysis, including all cohort studies presently available, shows that there is insufficient evidence to confirm that chronic HBV infection is a new risk factor of MM.

…”

“…criteria. 1,[5][6][7][8][9] The pooled OR from these six cohort studies was 1.23 (95% CI 0.89-1.69; P = 0.202; I 2 = 22.8%; P herterogeneity = 0.262) with no statistical significance ( Figure 1).…”

Letter: the Shock Index and predicting outcomes in patients with upper gastrointestinal bleeding

“…In patients undergoing upper endoscopy, a pre-endoscopy risk assessment score was recorded in only 34% (125/367). 1 Even when tools were used they were often wrongly calculated. The low compliance with the recommended dedicated risk scores for upper GI bleeding combined with the absence of a validated risk scoring system for lower GI bleeding at the time of data collection (2013) prevented their use in the NCEPOD study.…”